-
1
-
-
25144491548
-
Osteopontin expression and prognostic significance in non-small cell lung cancer
-
DOI 10.1158/1078-0432.CCR-05-0541
-
Donati V, Boldrini L, Dell'Omodarme M, et al. Osteopontin expression and prognostic significance in non-small cell lung cancer. Clin Cancer Res 2005; 11:6459-65. (Pubitemid 41338982)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.18
, pp. 6459-6465
-
-
Donati, V.1
Boldrini, L.2
Dell'Omodarme, M.3
Prati, M.C.4
Faviana, P.5
Camacci, T.6
Lucchi, M.7
Mussi, A.8
Santoro, M.9
Basolo, F.10
Fontanini, G.11
-
2
-
-
0036300894
-
Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors
-
Chan DC, Earle KA, Zhao TL, et al. Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors. Clin Cancer Res 2002; 8:904-12. (Pubitemid 34742124)
-
(2002)
Clinical Cancer Research
, vol.8
, Issue.3
, pp. 904-912
-
-
Chan, D.C.1
Earle, K.A.2
Zhao, T.L.M.3
Helfrich, B.4
Zeng, C.5
Baron, A.6
Whitehead, C.M.7
Piazza, G.8
Pamukcu, R.9
Thompson, W.J.10
Alila, H.11
Nelson, P.12
Bunn Jr., P.A.13
-
3
-
-
0242456170
-
Axis of evil: Molecular mechanisms of cancer metastasis
-
Bogenrieder T, Herlyn M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 2003; 22:6524-36. (Pubitemid 37372332)
-
(2003)
Oncogene
, vol.22
, Issue.43
, pp. 6524-6536
-
-
Bogenrieder, T.1
Herlyn, M.2
-
4
-
-
0033595125
-
Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells
-
DOI 10.1038/sj.onc.1202799
-
Tuck AB, Arsenault DM, O'Malley FP, et al. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells. Oncogene 1999; 18:4237-46. (Pubitemid 29377854)
-
(1999)
Oncogene
, vol.18
, Issue.29
, pp. 4237-4246
-
-
Tuck, A.B.1
Arsenault, D.M.2
O'Malley, F.P.3
Hota, C.4
Ling, M.C.5
Wilson, S.M.6
Chambers, A.F.7
-
5
-
-
33645079888
-
An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers
-
Le QT, Chen E, Salim A, et al. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res 2006; 12:1507-14.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 1507-1514
-
-
Le, Q.T.1
Chen, E.2
Salim, A.3
-
6
-
-
0142026839
-
Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth
-
DOI 10.1016/S0304-3835(03)00286-6
-
Hirama M, Takahashi F, Takahashi K, et al. Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth. Cancer Lett 2003, 198:107-17. (Pubitemid 37289110)
-
(2003)
Cancer Letters
, vol.198
, Issue.1
, pp. 107-117
-
-
Hirama, M.1
Takahashi, F.2
Takahashi, K.3
Akutagawa, S.4
Shimizu, K.5
Soma, S.6
Shimanuki, Y.7
Nishio, K.8
Fukuchi, Y.9
-
7
-
-
0030912190
-
Revisions in the international system for staging lung cancer
-
Mountain CF. Revision in the international system for staging lung cancer. Chest 1997; 111:1710-7. (Pubitemid 27260107)
-
(1997)
Chest
, vol.111
, Issue.6
, pp. 1710-1717
-
-
Mountain, C.F.1
-
10
-
-
0033731371
-
Osteopontin: A versatile regulator of inflammation and biomineralization
-
Giachelli CM, Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol 2000;19:615-22.
-
(2000)
Matrix Biol
, vol.19
, pp. 615-622
-
-
Giachelli, C.M.1
Steitz, S.2
-
11
-
-
0033829723
-
Vascular endothelial growth factor and osteopontin in tumor biology
-
Shijubo N, Uede T, Kon S, et al. Vascular endothelial growth factor and osteopontin in tumor biology. Crit Rev Oncod 2000; 11:135-46.
-
(2000)
Crit Rev Oncod
, vol.11
, pp. 135-146
-
-
Shijubo, N.1
Uede, T.2
Kon, S.3
-
12
-
-
0035021027
-
Osteopontin as a means to cope with environmental insults: Regulation of inflammation, tissue remodeling, and cell survival
-
Denhardt DT, Noda M, O'Regan AW, et al. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodelling, and cell survival. J Clin Invest 2001; 107:1055-61. (Pubitemid 32422899)
-
(2001)
Journal of Clinical Investigation
, vol.107
, Issue.9
, pp. 1055-1061
-
-
Denhardt, D.T.1
Noda, M.2
O'Regan, A.W.3
Pavlin, D.4
Berman, J.S.5
-
13
-
-
0037102376
-
Autocrine stimulation by osteopontin contributes to antiapoptotic signalling of melanocytes in dermal collagen
-
Geissinger E, Weisser C, Fischer P, et al. Autocrine stimulation by osteopontin contributes to antiapoptotic signalling of melanocytes in dermal collagen. Cancer Res 2002; 62:4820-8.
-
(2002)
Cancer Res
, vol.62
, pp. 4820-4828
-
-
Geissinger, E.1
Weisser, C.2
Fischer, P.3
-
14
-
-
0034778882
-
Expression, roles, receptors, and regulation of osteopontin in the kidney
-
DOI 10.1046/j.1523-1755.2001.00032.x
-
Xie Y, Sakatsume M, Nishi S, et al. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 2001; 60:1645-57. (Pubitemid 32999968)
-
(2001)
Kidney International
, vol.60
, Issue.5
, pp. 1645-1657
-
-
Xie, Y.1
Sakatsume, M.2
Nishi, S.3
Narita, I.4
Arakawa, M.5
Gejyo, F.6
-
15
-
-
0032784057
-
Osteopontin: Possible role in prostate cancer progression
-
Thalmann GN, Sikes RA, Devoll RE, et al. Osteopontin: possible role in prostate cancer progression. Clin Cancer Res 1999; 5:2271-7. (Pubitemid 29399287)
-
(1999)
Clinical Cancer Research
, vol.5
, Issue.8
, pp. 2271-2277
-
-
Thalmann, G.N.1
Sikes, R.A.2
Devoll, R.E.3
Kiefer, J.A.4
Markwalder, R.5
Klima, I.6
Farach-Carson, C.M.7
Studer, U.E.8
Chung, L.W.K.9
-
16
-
-
0037012338
-
Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling
-
Agrawal D, Chen T, Irby R, et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 2002; 94:513-21. (Pubitemid 34411290)
-
(2002)
Journal of the National Cancer Institute
, vol.94
, Issue.7
, pp. 513-521
-
-
Agrawal, D.1
Chen, T.2
Irby, R.3
Quackenbush, J.4
Chambers, A.F.5
Szabo, M.6
Cantor, A.7
Coppola, D.8
Yeatman, T.J.9
-
17
-
-
27644526912
-
Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer
-
DOI 10.1158/1078-0432.CCR-04-2013
-
Hu Z, Lin D, Yuan J, et al. Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer. Clin Cancer Res 2005; 11:4646-52. (Pubitemid 41557181)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.13
, pp. 4646-4652
-
-
Hu, Z.1
Lin, D.2
Yuan, J.3
Xiao, T.4
Zhang, H.5
Sun, W.6
Han, N.7
Ma, Y.8
Di, X.9
Gao, M.10
Ma, J.11
Zhang, J.12
Cheng, S.13
Gao, Y.14
-
18
-
-
1642576134
-
Correlation of Osteopontin Protein Expression and Pathological Stage across a Wide Variety of Tumor Histologies
-
DOI 10.1158/1078-0432.CCR-1405-2
-
Coppola D, Szabo M, Boulware D, et al. Correlation of Osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 2004, 10:184-90. (Pubitemid 38114178)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.1 I
, pp. 184-190
-
-
Coppola, D.1
Szabo, M.2
Boulware, D.3
Muraca, P.4
Alsarraj, M.5
Chambers, A.F.6
Yeatman, T.J.7
-
19
-
-
0035678921
-
Osteopontin (OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent
-
Tuck AB, Hota C, Chambers AF. Osteopontin (OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent. Breast Cancer Res Treat 2001; 70:197-204.
-
(2001)
Breast Cancer Res Treat
, vol.70
, pp. 197-204
-
-
Tuck, A.B.1
Hota, C.2
Chambers, A.F.3
-
20
-
-
2542434974
-
Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer
-
DOI 10.1158/1078-0432.CCR-03-0365
-
Schorge JO, Drake RD, Lee H, et al. Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer. Clin Cancer Res 2004; 10:3474-8. (Pubitemid 38685455)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.10
, pp. 3474-3478
-
-
Schorge, J.O.1
Drake, R.D.2
Lee, H.3
Skates, S.J.4
Rajanbabu, R.5
Miller, D.S.6
Kim, J.-H.7
Cramer, D.W.8
Berkowitz, R.S.9
Mok, S.C.10
-
21
-
-
19444384643
-
Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma
-
DOI 10.1016/j.ejso.2005.01.005, PII S0748798305000065
-
Wong TS, Kwong DL, Sham J, et al. Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma. Eur J Surg Oncol 2005; 31:555-8. (Pubitemid 40724099)
-
(2005)
European Journal of Surgical Oncology
, vol.31
, Issue.5
, pp. 555-558
-
-
Wong, T.S.1
Kwong, D.L.-W.2
Sham, J.3
Wei, W.I.4
Kwong, Y.L.5
Yuen, A.P.-W.6
-
22
-
-
0037096898
-
Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer
-
Rudland PS, Platt-Higgins A, EI-Tanani M, et al. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Cancer Res 2002; 62:3417-27. (Pubitemid 34651388)
-
(2002)
Cancer Research
, vol.62
, Issue.12
, pp. 3417-3427
-
-
Rudland, P.S.1
Platt-Higgins, A.2
El-Tanani, M.3
De Silva, R.S.4
Barraclough, R.5
Winstanley, J.H.R.6
Howitt, R.7
West, C.R.8
-
23
-
-
69549097610
-
Serum osteopontin levels are highly prognostic for survival in advanced non-small cell lung cancer: Results from JMTO LC 0004
-
Isa S, Kawaguchi T, Teramukai S, et al. Serum osteopontin levels are highly prognostic for survival in advanced non-small cell lung cancer: results from JMTO LC 0004. J Thorac Oncol 2009; 4:1104-10.
-
(2009)
J Thorac Oncol
, vol.4
, pp. 1104-1110
-
-
Isa, S.1
Kawaguchi, T.2
Teramukai, S.3
-
24
-
-
54249152439
-
Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003
-
Mack PC, Redman MW, Chansky K, et al. Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003. J Clin Oncol 2008; 26:4771-6.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4771-4776
-
-
Mack, P.C.1
Redman, M.W.2
Chansky, K.3
-
25
-
-
34548047714
-
Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer
-
DOI 10.1016/j.lungcan.2007.04.005, PII S0169500207002218
-
Chang YS, Kim HJ, Chang J, et al. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer. Lung Cancer 2007; 57:373-80. (Pubitemid 47285428)
-
(2007)
Lung Cancer
, vol.57
, Issue.3
, pp. 373-380
-
-
Chang, Y.S.1
Kim, H.J.2
Chang, J.3
Ahn, C.M.4
Kim, S.K.5
Kim, S.K.6
|